Ventyx Biosciences Inc expected to post a loss of 64 cents a share - Earnings Preview

Ventyx Biosciences

21/03/2023 20:48

* Ventyx Biosciences Inc  VTYX.OQ   VTYX.O  is expected
to show no
change in quarterly revenue when it reports  results on March
23. 
    * 
    * ​Refinitiv's mean analyst estimate for Ventyx Biosciences
Inc is
for a loss of 64 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ventyx
Biosciences Inc is $55.5​, above​ its last closing price
of $37.85. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.43       -0.44      -0.59     Missed  -33.7
 Jun. 30 2022  -0.46       -0.45      -0.39     Beat    13.3
 Mar. 31 2022  -0.51       -0.52      -0.45     Beat    13.4​
 Dec. 31 2021  -0.32       -1.00      -0.36     Beat    64.1
 ​​Sep.        -0.36       -0.36      -3.17     Missed  -780.6
 30 2021                                                
                                                        ​
 This summary was machine generated March 21 at 20:48 GMT.  All
figures in US dollars  unless otherwise stated